Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SANUWAVE Health (SNWV) Common Equity (2023 - 2025)

SANUWAVE Health (SNWV) has disclosed Common Equity for 9 consecutive years, with $1.6 million as the latest value for Q4 2025.

  • Quarterly Common Equity rose 110.25% to $1.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.6 million through Dec 2025, up 110.25% year-over-year, with the annual reading at $1.6 million for FY2025, 110.25% up from the prior year.
  • Common Equity for Q4 2025 was $1.6 million at SANUWAVE Health, up from -$7.6 million in the prior quarter.
  • The five-year high for Common Equity was $1.6 million in Q4 2025, with the low at -$66.0 million in Q3 2023.
  • Average Common Equity over 3 years is -$36.2 million, with a median of -$42.1 million recorded in 2023.
  • The sharpest move saw Common Equity grew 8.63% in 2024, then soared 110.25% in 2025.
  • Over 3 years, Common Equity stood at -$44.5 million in 2023, then skyrocketed by 64.54% to -$15.8 million in 2024, then skyrocketed by 110.25% to $1.6 million in 2025.
  • According to Business Quant data, Common Equity over the past three periods came in at $1.6 million, -$7.6 million, and -$18.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.